Funder
National Institutes of Health
National Institute on Drug Abuse
Fogarty International Center
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous)
Reference43 articles.
1. Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am. J. Public Health [Internet]. 2015;105:e55-63. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/26066931
.
2. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378–82. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/26720857
.
3. Nosyk B, Douglas Anglin M, Brissette S, Kerr T, Marsh DC, Schackman BR, et al. A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Aff. 2013;32:1462–9.
4. Romero Mendoza M, Medina-Mora M, González H, Vásquez J, Armas G, Magis C. Guía para el uso de metadona en usuarios adultos con VIH dependientes de la heroína intravenosa. México. 2016.
5. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am. J. Public Health. 2009;99:221–7.
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献